{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:58:01Z","timestamp":1791021481726,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2016R1A5A1010764"],"award-info":[{"award-number":["NRF-2016R1A5A1010764"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is increasing concern regarding cardiovascular risk in individuals with non-alcoholic fatty liver disease. This study was conducted to evaluate whether hepatic steatosis with or without fibrosis is associated with the progression of carotid atherosclerosis in patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From a longitudinal cohort, we enrolled 1120 patients with type 2 diabetes who underwent repeated carotid artery ultrasonography every 1\u20132\u00a0years. Ultrasonographic findings at baseline and after 6\u20138\u00a0years were compared. Presence of hepatic steatosis was mainly assessed by abdominal ultrasonography; patients with hepatic steatosis were further evaluated for hepatic fibrosis according to fibrosis-4 index. We investigated the association between liver status and atherosclerosis progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 1120 patients, 636 (56.8%) were classified as having hepatic steatosis at baseline. After 6\u20138\u00a0years, 431 (38.5%) showed atherosclerosis progression. Hepatic steatosis was significantly associated with atherosclerosis progression (adjusted odds ratio[AOR]: 1.370, 95% CI 1.025\u20131.832;\n                      <jats:italic>p\u2009<\/jats:italic>\n                      &lt;\u20090.05). Among patients with hepatic steatosis, only individuals with fibrosis showed significant association with atherosclerosis progression (AOR: 1.615, 95% CI 1.005\u20132.598;\n                      <jats:italic>p\u2009<\/jats:italic>\n                      &lt;\u20090.05). The association between hepatic fibrosis and atherosclerosis progression was significant in all metabolic subgroups regardless of age, body mass index, presence of metabolic syndrome, or insulin sensitivity (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Furthermore, subjects with hepatic steatosis &amp; fibrosis and\u2009\u2265\u20094 components of metabolic syndrome criteria showed markedly increased risk of atherosclerosis progression (AOR: 2.430, 95% CI 1.087\u20135.458;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hepatic steatosis with fibrosis is independently associated with the progression of carotid atherosclerosis in patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-020-01064-x","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T09:02:54Z","timestamp":1592038974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Hyeok-Hee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Wook","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Wan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Soo","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-4942","authenticated-orcid":false,"given":"Yong-ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kap Bum","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,13]]},"reference":[{"issue":"11","key":"1064_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"3","key":"1064_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0035-1562944","volume":"35","author":"E Vanni","year":"2015","unstructured":"Vanni E, Marengo A, Mezzabotta L, Bugianesi E. Systemic complications of nonalcoholic fatty liver disease: when the liver is not an innocent bystander. Semin Liver Dis. 2015;35(3):236\u201349.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"1064_CR3","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1210\/jc.2013-4133","volume":"99","author":"SK Kim","year":"2014","unstructured":"Kim SK, Choi YJ, Huh BW, Park SW, Lee EJ, Cho YW, et al. Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab. 2014;99(5):1879\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1064_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.09.012","volume":"204","author":"HC Kim","year":"2009","unstructured":"Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis. 2009;204(2):521\u20135.","journal-title":"Atherosclerosis."},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2016.01.016","volume":"246","author":"AL Fracanzani","year":"2016","unstructured":"Fracanzani AL, Tiraboschi S, Pisano G, Consonni D, Baragetti A, Bertelli C, et al. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10\u00a0years of follow-up. Atherosclerosis. 2016;246:208\u201313.","journal-title":"Atherosclerosis."},{"issue":"10","key":"1064_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","volume":"33","author":"LS Bhatia","year":"2012","unstructured":"Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012;33(10):1190\u2013200.","journal-title":"Eur Heart J"},{"issue":"6","key":"1064_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","volume":"41","author":"E Han","year":"2017","unstructured":"Han E, Lee YH. Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases. Diabetes Metab J. 2017;41(6):430\u20137.","journal-title":"Diabetes Metab J."},{"issue":"8","key":"1064_CR8","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology. 2016;150(8):1769\u201377.","journal-title":"Gastroenterology"},{"issue":"4","key":"1064_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865\u201373.","journal-title":"Hepatology"},{"issue":"2","key":"1064_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2006.04.006","volume":"191","author":"RK Schindhelm","year":"2007","unstructured":"Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD, Heine RJ, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis. 2007;191(2):391\u20136.","journal-title":"Atherosclerosis."},{"issue":"3","key":"1064_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"4","key":"1064_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.amjcard.2019.05.028","volume":"124","author":"E Oni","year":"2019","unstructured":"Oni E, Budoff MJ, Zeb I, Li D, Veledar E, Polak JF, et al. Nonalcoholic fatty liver disease is associated with arterial distensibility and carotid intima-media thickness: (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2019;124(4):534\u20138.","journal-title":"Am J Cardiol"},{"issue":"11","key":"1064_CR13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/MEG.0000000000000429","volume":"27","author":"SA Madan","year":"2015","unstructured":"Madan SA, John F, Pyrsopoulos N, Pitchumoni CS. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis. Eur J Gastroenterol Hepatol. 2015;27(11):1237\u201348.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"1064_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","volume":"49","author":"S Sookoian","year":"2008","unstructured":"Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008;49(4):600\u20137.","journal-title":"J Hepatol"},{"issue":"3","key":"1064_CR15","doi-asserted-by":"publisher","first-page":"481\u20138 e1","DOI":"10.1053\/j.gastro.2016.06.001","volume":"151","author":"DH Sinn","year":"2016","unstructured":"Sinn DH, Cho SJ, Gu S, Seong D, Kang D, Kim H, et al. Persistent nonalcoholic fatty liver disease increases risk for carotid atherosclerosis. Gastroenterology. 2016;151(3):481\u20138 e1.","journal-title":"Gastroenterology"},{"issue":"1","key":"1064_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"key":"1064_CR17","doi-asserted-by":"publisher","unstructured":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","DOI":"10.1016\/j.jhep.2015.11.004"},{"issue":"1","key":"1064_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4093\/dmj.2019.0011","volume":"43","author":"YH Lee","year":"2019","unstructured":"Lee YH, Cho Y, Lee BW, Park CY, Lee DH, Cha BS, et al. Nonalcoholic fatty liver disease in diabetes. Part I: epidemiology and diagnosis. Diabetes Metab J. 2019;43(1):31\u201345.","journal-title":"Diabetes Metab J."},{"issue":"6","key":"1064_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1161\/01.ATV.0000072273.67342.6D","volume":"23","author":"LE Wagenknecht","year":"2003","unstructured":"Wagenknecht LE, Zaccaro D, Espeland MA, Karter AJ, O\u2019Leary DH, Haffner SM. Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 2003;23(6):1035\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1064_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4093\/dmj.2017.0106","volume":"42","author":"JH Baek","year":"2018","unstructured":"Baek JH, Kim H, Kim KY, Jung J. Insulin resistance and the risk of diabetes and dysglycemia in Korean general adult population. Diabetes Metab J. 2018;42(4):296\u2013307.","journal-title":"Diabetes Metab J."},{"issue":"5","key":"1064_CR21","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/jgh.14011","volume":"33","author":"EY Choe","year":"2018","unstructured":"Choe EY, Lee YH, Choi YJ, Huh BW, Lee BW, Kim SK, et al. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes. J Gastroenterol Hepatol. 2018;33(5):1082\u201391.","journal-title":"J Gastroenterol Hepatol"},{"key":"1064_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"issue":"6","key":"1064_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med."},{"key":"1064_CR24","doi-asserted-by":"publisher","unstructured":"Chapter 1: definition and classification of CKD. Kidney Int Suppl. 2013;3(1):19\u201362. https:\/\/doi.org\/10.1038\/kisup.2012.64.","DOI":"10.1038\/kisup.2012.64"},{"issue":"1","key":"1064_CR25","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.diabres.2008.07.010","volume":"82","author":"R Sharma","year":"2008","unstructured":"Sharma R, Vikram NK, Misra A. Comparison of short insulin tolerance test with HOMA Method for assessment of insulin sensitivity in Asian Indians in north India. Diabetes Res Clin Pract. 2008;82(1):e9\u201312.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1064_CR26","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3349\/ymj.2008.49.6.901","volume":"49","author":"MY Lee","year":"2008","unstructured":"Lee MY, Koh JH, Nam SM, Jung PM, Sung JK, Kim SY, et al. Short insulin tolerance test can determine the effects of thiazolidinediones treatment in type 2 diabetes. Yonsei Med J. 2008;49(6):901\u20138.","journal-title":"Yonsei Med J"},{"issue":"16","key":"1064_CR27","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"key":"1064_CR28","unstructured":"World Health Organization. Regional Office for the Western P. The Asia-Pacific perspective: redefining obesity and its treatment: Sydney: Health Communications Australia; 2000."},{"issue":"9","key":"1064_CR29","doi-asserted-by":"publisher","first-page":"e107584","DOI":"10.1371\/journal.pone.0107584","volume":"9","author":"YH Lee","year":"2014","unstructured":"Lee YH, Bang H, Park YM, Bae JC, Lee BW, Kang ES, et al. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. PLoS ONE. 2014;9(9):e107584.","journal-title":"PLoS ONE"},{"issue":"1","key":"1064_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32\u20136.","journal-title":"Hepatology."},{"issue":"4","key":"1064_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jacc.2014.11.019","volume":"65","author":"Y Qi","year":"2015","unstructured":"Qi Y, Fan J, Liu J, Wang W, Wang M, Sun J, et al. Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study. J Am Coll Cardiol. 2015;65(4):355\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1064_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0009-9236(97)90166-1","volume":"61","author":"EA Sotaniemi","year":"1997","unstructured":"Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther. 1997;61(3):331\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"1064_CR33","first-page":"2057","volume":"19","author":"I Elfaki","year":"2018","unstructured":"Elfaki I, Mir R, Almutairi FM, Duhier FMA. Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis. Asian Pac J Cancer Prev. 2018;19(8):2057\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"1064_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/07853890701379767","volume":"39","author":"PV Luoma","year":"2007","unstructured":"Luoma PV. Cytochrome P450\u2013physiological key factor against cholesterol accumulation and the atherosclerotic vascular process. Ann Med. 2007;39(5):359\u201370.","journal-title":"Ann Med"},{"issue":"3","key":"1064_CR35","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/hep.24107","volume":"53","author":"T Li","year":"2011","unstructured":"Li T, Matozel M, Boehme S, Kong B, Nilsson LM, Guo G, et al. Overexpression of cholesterol 7\u03b1-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology. 2011;53(3):996\u20131006.","journal-title":"Hepatology"},{"issue":"4","key":"1064_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","volume":"115","author":"MW Lorenz","year":"2007","unstructured":"Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459\u201367.","journal-title":"Circulation"},{"issue":"1","key":"1064_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.diabet.2012.11.002","volume":"39","author":"K Gariani","year":"2013","unstructured":"Gariani K, Philippe J, Jornayvaz F. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab. 2013;39(1):16\u201326.","journal-title":"Diabetes Metab."},{"issue":"4","key":"1064_CR38","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3349\/ymj.2017.58.4.756","volume":"58","author":"BH Park","year":"2017","unstructured":"Park BH, Yoon JM, Kim JH, Moon JH, Lee YH, Jang SM, et al. Pathologic impact of insulin resistance and sensitivity on the severity of liver histopathology in pediatric non-alcoholic steatohepatitis. Yonsei Med J. 2017;58(4):756\u201362.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1064_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-019-0976-0","volume":"18","author":"PC Brar","year":"2019","unstructured":"Brar PC, Chun A, Fan X, Jani V, Craft M, Bhatla P, et al. Impaired myocardial deformation and ventricular vascular coupling in obese adolescents with dysglycemia. Cardiovasc Diabetol. 2019;18(1):172.","journal-title":"Cardiovasc Diabetol."},{"issue":"2","key":"1064_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.atherosclerosis.2015.02.011","volume":"239","author":"M Al Rifai","year":"2015","unstructured":"Al Rifai M, Silverman MG, Nasir K, Budoff MJ, Blankstein R, Szklo M, et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2015;239(2):629\u201333.","journal-title":"Atherosclerosis."},{"issue":"37","key":"1064_CR41","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.3748\/wjg.v20.i37.13306","volume":"20","author":"S Fargion","year":"2014","unstructured":"Fargion S, Porzio M, Fracanzani AL. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World J Gastroenterol. 2014;20(37):13306\u201324.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1064_CR42","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1440-1746.2009.06196.x","volume":"25","author":"E Kathirvel","year":"2010","unstructured":"Kathirvel E, Chen P, Morgan K, French SW, Morgan TR. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol. 2010;25(6):1136\u201343.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1064_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","volume":"227","author":"AP DeFilippis","year":"2013","unstructured":"DeFilippis AP, Blaha MJ, Martin SS, Reed RM, Jones SR, Nasir K, et al. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2013;227(2):429\u201336.","journal-title":"Atherosclerosis."},{"issue":"2","key":"1064_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","volume":"14","author":"F Marra","year":"2008","unstructured":"Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med. 2008;14(2):72\u201381.","journal-title":"Trends Mol Med."},{"issue":"3","key":"1064_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-0029-1222606","volume":"35","author":"G Targher","year":"2009","unstructured":"Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost. 2009;35(3):277\u201387.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"1064_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-018-0670-7","volume":"17","author":"A Tuttolomondo","year":"2018","unstructured":"Tuttolomondo A, Petta S, Casuccio A, Maida C, Corte VD, Daidone M, et al. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Cardiovasc Diabetol. 2018;17(1):28.","journal-title":"Cardiovasc Diabetol."},{"issue":"8","key":"1064_CR47","doi-asserted-by":"publisher","first-page":"e0202666","DOI":"10.1371\/journal.pone.0202666","volume":"13","author":"A Gummesson","year":"2018","unstructured":"Gummesson A, Str\u00f6mberg U, Schmidt C, Kullberg J, Anger\u00e5s O, Lindgren S, et al. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: a cross-sectional, population-based study in middle-aged subjects. PLoS ONE. 2018;13(8):e0202666.","journal-title":"PLoS ONE"},{"issue":"6","key":"1064_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MCA.0b013e3282583c0d","volume":"18","author":"U Arslan","year":"2007","unstructured":"Arslan U, Turkoglu S, Balcioglu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007;18(6):433\u20136.","journal-title":"Coron Artery Dis"},{"issue":"19","key":"1064_CR49","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.4103\/0366-6999.241797","volume":"131","author":"YC Guo","year":"2018","unstructured":"Guo YC, Zhou Y, Gao X, Yao Y, Geng B, Cui QH, et al. Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population: a Cross-Sectional Study. Chin Med J (Engl). 2018;131(19):2269\u201376.","journal-title":"Chin Med J (Engl)."},{"issue":"2","key":"1064_CR50","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.4103\/jfmpc.jfmpc_957_19","volume":"9","author":"V Rampally","year":"2020","unstructured":"Rampally V, Biri SK, Nair IK, Vadlakonda A. Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals. J Family Med Prim Care. 2020;9(2):1182\u20136.","journal-title":"J Family Med Prim Care."},{"issue":"1","key":"1064_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12933-019-0864-7","volume":"18","author":"JC Fruchart","year":"2019","unstructured":"Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, et al. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM\u03b1) paradigm: conceptual framework and therapeutic potential: a consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. Cardiovasc Diabetol. 2019;18(1):71.","journal-title":"Cardiovasc Diabetol."},{"issue":"2","key":"1064_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","volume":"7","author":"N Rafiq","year":"2009","unstructured":"Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"1064_CR53","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.4254\/wjh.v7.i10.1369","volume":"7","author":"H Azzam","year":"2015","unstructured":"Azzam H, Malnick S. Non-alcoholic fatty liver disease\u2014the heart of the matter. World J Hepatol. 2015;7(10):1369\u201376.","journal-title":"World J Hepatol."},{"issue":"1","key":"1064_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-020-01025-4","volume":"19","author":"JH Kim","year":"2020","unstructured":"Kim JH, Moon JS, Byun SJ, Lee JH, Kang DR, Sung KC, et al. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study. Cardiovasc Diabetol. 2020;19(1):51.","journal-title":"Cardiovasc Diabetol."},{"issue":"2","key":"1064_CR55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","volume":"68","author":"A Lonardo","year":"2018","unstructured":"Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018;68(2):335\u201352.","journal-title":"J Hepatol"},{"issue":"4","key":"1064_CR56","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/ijms17040460","volume":"17","author":"CA Villela-Nogueira","year":"2016","unstructured":"Villela-Nogueira CA, Leite NC, Cardoso CR, Salles GF. NAFLD and increased aortic stiffness: parallel or common physiopathological mechanisms? Int J Mol Sci. 2016;17(4):460.","journal-title":"Int J Mol Sci."},{"issue":"10","key":"1064_CR57","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1080\/00365520903171284","volume":"44","author":"S Dam-Larsen","year":"2009","unstructured":"Dam-Larsen S, Becker U, Franzmann MB, Larsen K, Christoffersen P, Bendtsen F. Final results of a long-term, clinical follow-up in fatty liver patients. Scand J Gastroenterol. 2009;44(10):1236\u201343.","journal-title":"Scand J Gastroenterol"},{"issue":"S1","key":"1064_CR58","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43(S1):S99\u2013112.","journal-title":"Hepatology"},{"issue":"5","key":"1064_CR59","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66(5):1486\u2013501.","journal-title":"Hepatology"},{"issue":"8","key":"1064_CR60","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW Wong","year":"2018","unstructured":"Wong VW, Adams LA, de Ledinghen V, Wong GL, Sookoian S. Noninvasive biomarkers in NAFLD and NASH\u2014current progress and future promise. Nat Rev Gastroenterol Hepatol. 2018;15(8):461\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-020-01064-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:07:54Z","timestamp":1623524874000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-020-01064-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,13]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1186\/s12933-020-01064-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23583\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23583\/v2","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,13]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with the Declaration of Helsinki and was approved by the Ethics Committee of the Yonsei University College of Medicine (4-2019-0270). All participants provided written informed consent in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}